logo
  

HPV Vaccine Offers Long-Term Protection, Study Finds

hypodermicneedle 052812 10Jul12

A new study suggests that the human papillomavirus (HPV) vaccine can protect people for at least eight years.

In this study, published in the journal Pediatrics, researchers recruited 1,781 boys and girls between the ages of nine and 15 who were not sexually active. The participants were randomly assigned to the vaccine or the placebo group. The researchers conducted a follow-up study to look for the presence of antibodies against HPV after eight years.

Researchers found that in the vaccine group, boys and girls had signs of antibodies, which suggested that the vaccine is effective.

"It is very promising that we now know that we are going to have protection for at least eight years," said Dr. Adriana Cadilla, a pediatrician at Miami Children's Hospital.

For comments and feedback contact: editorial@rttnews.com

Health News

All eyes were on the U.S. Federal Reserve this week as the bank announced its latest policy decision. Find out the signals given out by Chair Jerome Powell regarding the future path of interest rates. Some key data on the U.S. private sector economy were also released. Other main news included the flash estimates of first quarter GDP from Eurozone. Elsewhere, the Paris-based think tank OECD released its latest round of macroeconomic projections for the global economy.

View More Videos
Follow RTT